Hisham Shiblaq - Mar 31, 2022 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role: EVP, Chief Comm. Officer
Signature: /s/ Alaleh Nouri, Attorney-in-Fact for Hisham Shiblaq
Stock symbol: PRCT
Transactions as of: Mar 31, 2022
Transactions value $: $114,993
Form type: 4
Date filed: 4/4/2022, 05:17 PM
Previous filing: Sep 14, 2021
Next filing: Jan 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRCT	Common Stock	Award	$115K	+3.91K	+8.92%	$29.38	47.8K	Mar 31, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRCT	Stock Option (Right to Buy)	Award	$0	+7.92K		$0.00	7.92K	Mar 31, 2022	Common Stock	7.92K	$34.99	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 15, 2023, with one-quarter of the remaining RSUs vesting annually on each of the second, third, and fourth anniversary thereof, subject to the Reporting Person continuing as a service provider through such date.
F2	The Stock option was granted on March 31, 2022 and vests 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.